Related Experiment Video
Updated: May 26, 2026

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
The profile of inflammatory and metabolic response in children undergoing heart transplantation
Xiaoyang Yu1, Bodil Larsen, Simon Urschel
1Division of Pediatric Cardiology, Stollery Children's Hospital, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
Insights
Pediatric heart transplantation (HTx) shows significant inflammatory and metabolic changes. C-reactive protein (CRP) and prealbumin (PA) levels indicate a heightened response post-surgery, influenced by cardiopulmonary bypass duration.
Area of Science:
- Pediatric Cardiology
- Transplant Immunology
- Biomarkers in Critical Care
Background:
- Clinical outcomes after pediatric heart transplantation (HTx) are influenced by inflammatory and metabolic responses, but these are not well-characterized in this population.
- Understanding these perioperative changes is crucial for optimizing patient management and improving long-term results.
Purpose of the Study:
- To investigate the perioperative changes in inflammatory (C-reactive protein, CRP) and metabolic (prealbumin, PA) markers in children undergoing heart transplantation.
- To identify factors influencing these biomarker changes during the perioperative period.
Main Methods:
- Prospective study of 38 children undergoing HTx.
- Collection of data on CRP, PA, white blood cell counts, medication dosages, cultures, and surgical parameters (CPB, ischemia time, cross-clamp time) before and up to one month after HTx.
- Statistical analysis to correlate biomarker levels with clinical and surgical variables.
Main Results:
- CRP levels were elevated before HTx, peaked on postoperative days 1-2, and decreased by one month. PA levels decreased initially post-HTx before gradually increasing.
- Postoperative CRP levels correlated positively with epinephrine dosage and cardiopulmonary bypass (CPB) duration.
- Prealbumin levels showed a positive correlation with patient age.
Conclusions:
- Children undergoing heart transplantation exhibit a distinct inflammatory and metabolic response profile perioperatively.
- The intensity of this response is significantly influenced by the duration of cardiopulmonary bypass and the patient's cardiovascular function.
- These findings highlight the importance of monitoring CRP and PA in pediatric HTx patients to assess recovery and potential complications.
Abstract:
Inflammatory and metabolic response is an important factor to determine clinical outcomes. However, it remains unknown in children undergoing heart transplantation (HTx). We examined the perioperative changes in the inflammatory and metabolic response markers C-reactive protein (CRP) and prealbumin (PA) in 38 heart-transplanted children. Data obtained prior to and within one month after HTx included CRP, PA, total and differential white blood cell counts, doses of inotropes and immunosuppressants, cultures of blood and body fluids, duration of cardiopulmonary bypass (CPB), aortic cross clamp and donor heart ischemia, and days in the intensive care unit (ICU) and hospital. CRP was 32±49 mg/L before HTx, increased to 130±55 mg/L on postoperative day 1-2, and decreased to 21±31 mg/L by one month after HTx. PA was 0.15±0.06 g/L before HTx, decreased to 0.12±0.03 g/L on postoperative day 1-2, and then gradually increased to 0.21±0.10 g/L by one month after HTx. Postoperative CRP positively correlated with epinephrine dosage and CPB duration. PA positively correlated with age. In conclusion, inflammatory and metabolic response is present before HTx and acutely intensified after HTx. It may be mainly influenced by CPB duration and cardiovascular function status.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Metabolism
